adi-001
adicet bio
['adi-001 ', 'adicet']
 announces positive clinical data including continued complete responses across dose levels and six-month durability for adi-001 at #ash2022! #celltherapy #cart #biotechnology #oncology 
A clinical stage biotechnology company discovering and developing allogeneic gamma-delta T cell therapies for cancer.